Skip to main content
Return on investment

biotech

Sean Ekins in his office.

Apr 6, 2023

Collaborations Pharmaceuticals uses AI to solve biotech challenges

From a series of lab and office suites on NC State’s Centennial Campus, Collaborations Pharmaceuticals is solving some of the biggest biotech challenges. 
Artist rendering of CAR-T cells.

Mar 25, 2022

In animal study, implant churns out CAR-T cells to combat cancer

In an animal study, the implants were faster and more effective than conventional CAR-T cell cancer treatment. 
African American researcher dressed in full protective gear working in the lab.

Oct 28, 2021

Return on investment

A subsidiary of Fujifilm Corporation, Fujifilm Diosynth Biotechnologies’ Holly Springs site will bring a planned 725 new highly skilled positions to North Carolina’s Research Triangle region by 2028 and represents a $2 billion investment in the state. It was a significant win for North Carolina economic developers, but is one of many notable biopharma announcements…